Diabetes

By Jonah Comstock November 16, 2017
Medical device software company Voluntis has received an updated FDA clearance (as well as an updated CE mark) for its Insulia app, a "digital companion" app for people with Type 2 diabetes. Insulia offers realtime basal insulin dose coaching, and the new clearance makes the app usable with two additional brands of insulin: Basaglar and Tresiba. The app had already worked for users of Lantus,...
By Dave Muoio November 14, 2017
During its Q3 earnings call, Israel-based DarioHealth announced a growing US install base for its smartphone-connected glucometer and increased revenues supported by increasing sales of the platform’s accompanying consumable test strips. While the company expects each of these to take an even larger bite from its cash burn in the coming months, CEO and Chairman Erez Raphael also highlighted...
By Laura Lovett November 10, 2017
A new study reveals that artificial intelligence could be a useful tool to help patients prevent Type 2 diabetes. The study, published in the Journal of Medical Internet Research, showed that patients at risk of Type 2 diabetes who used the Lark Weight Loss Health Coach AI, dropped 2.38 percent of their baseline weight and increase the percentage of healthful meals they ate by 31 percent.  “I’m...
By Jonah Comstock November 2, 2017
On Fitbit’s third quarter earnings call yesterday, the company shared that, between spending cuts and the launch of the its long-awaited smartwatch, the company is pulling out of the earnings slump it’s been experiencing. The call also saw CEO James Park talking more than ever about the fitness wearable’s clinical applications and the ways in which those ambitions are coming to fruition. This...
By Dave Muoio October 31, 2017
Fitbit’s wearables are at the heart of recent announcements from diabetes self-management platform One Drop and the City of Santa Monica’s Office of Civic Wellbeing. The first reveals an upcoming integration that will allow users to view Fitbit device data from within the One Drop Mobile app, while the latter describes a public health initiative that will provide residents of the city with Fitbit...
By Jonah Comstock October 26, 2017
Samsung has announced the latest spin-out companies to come through its C-Lab program, and two of the seven are mobile health companies: a phone overlay for people with presbyopia and a glucometer that attaches to a phone and uses its camera to analyze glucose levels. Samsung Electronics’ C-Lab in South Korea is an internal incubation program that first started in 2012 to help inspire a more...
By Dave Muoio October 18, 2017
Efforts to build artificial pancreas (AP) systems under open protocols will get a boost from JDRF, a multinational group that funds Type 1 diabetes research and other programs. The organization has announced a new initiative to not only provide funds for these DIY and frequently reverse engineered projects, but will also provide the regulatory and liability guidance necessary for a public release...
By Dave Muoio October 16, 2017
A novel artificial pancreas (AP) system with a smartphone backbone could automatically monitor and adjust patients' glucose levels with little to no hassle, according to a new clinical study published in the journal Diabetes Care. Unlike previously examined AP systems, the newest iteration — which consists of an insulin pump, continuous glucose monitoring receiver, a Bluetooth-connected...
By Dave Muoio October 16, 2017
Seattle-based Wellpepper, developers of a digital patient engagement service, have been announced the winners of the Alexa Diabetes Challenge for their voice-enabled diabetes support platform Sugarpod. Consisting of a scale, foot scanner, and mobile interface along with a Amazon Alexa voice functionality, Sugarpod is designed to support type 2 diabetes care plans by integrating engagement and...
By Jonah Comstock September 13, 2017
Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management company based in Piscataway, New Jersey in the US and Maharashtra in India. The terms of the acquisition were not disclosed. Though it was founded in 2012, Diabeto really hit the scene in 2015 with an...